NCT06265285 - Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IIB Cutaneous Melanoma AJCC v8Clinical Stage IIC Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8Esophageal CarcinomaGastroesophageal Junction AdenocarcinomaHepatocellular CarcinomaLocally Advanced Urothelial CarcinomaLung Non-Small Cell CarcinomaMalignant Solid NeoplasmMetastatic Colorectal CarcinomaMetastatic Cutaneous MelanomaMetastatic Esophageal Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Urothelial CarcinomaRecurrent Esophageal Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRenal Cell CarcinomaStage III Renal Cell Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage IV Renal Cell Cancer AJCC v8Unresectable Cutaneous MelanomaUnresectable Esophageal Squamous Cell CarcinomaUrothelial CarcinomaUnresectable Urothelial Carcinoma

Interventions

OTHER

Home Health Encounter

Receive in-home visits by a home health nurse

BIOLOGICAL

Nivolumab

Given SC

PROCEDURE

Patient Monitoring

Undergo remote patient monitoring

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville